Study Details
Full Title
XCA37: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (TNX-103-07)
Principal Investigator
Marat
Fudim
Protocol Number
PRO00119628
NCT ID
NCT07288398
Phase
III
Enrollment Status
Open to Enrollment